Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Spermatid perinuclear RNA-binding protein is coded by the *STRBP* gene on human chromosome 9. It is an RNA- and DNA-binding protein essential for spermatogenesis, influencing cell differentiation and growth within male germ cells. STRBP binds double-stranded DNA and RNA with a preference for poly(I:C) RNA, and also interacts with single-stranded poly(G) RNA and PRM1 mRNA[1][5][7]. It is predominantly localized in the nucleus and is functionally involved in cellular motility and mechanosensory behavior in germ cells. Disease associations are primarily related to hematologic cancers and cryptorchidism, but STRBP is not established as a direct drug target or biomarker[1][2][5][7].
Not applicable; no known drugs or inhibitors target this molecule directly
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Spermatid perinuclear RNA-binding protein (STRBP).